In order to investigate if JAM-C might also play a role in the actual destruction of β-cells and the immunopathogenesis of T1D, we blocked JAM-C with a neutralizing anti-JAM-C antibody that disrupts murine JAM-B/−C interactions [16]. The gene discussed is JAM2; the disease is type 1 diabetes mellitus.